|
|
|
Volumn 92, Issue 7, 2000, Pages 520-522
|
|
Antiangiogenesis drugs target specific cancer, mechanisms
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2 METHOXYESTRADIOL;
ALPHA INTERFERON;
ANGIOGENESIS INHIBITOR;
ANGIOSTATIN;
COMBRETASTATIN;
ENDOSTATIN;
IM 862;
MATRIX METALLOPROTEINASE INHIBITOR;
NOSE DROPS;
THALIDOMIDE;
UNCLASSIFIED DRUG;
ANGIOGENESIS;
BREAST CANCER;
CANCER;
CLINICAL TRIAL;
DRUG DELIVERY SYSTEM;
DRUG MECHANISM;
HUMAN;
LICENSING;
MELANOMA;
NONHUMAN;
NOTE;
OVARY CANCER;
PRIORITY JOURNAL;
THYROID TUMOR;
ANGIOSTATINS;
ANIMALS;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
BIBENZYLS;
HUMANS;
MATRIX METALLOPROTEINASES;
NEOPLASMS;
NEOVASCULARIZATION, PATHOLOGIC;
PEPTIDE FRAGMENTS;
PLASMINOGEN;
STILBENES;
|
|
EID: 0034607256
PISSN: 00278874
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (23)
|
|
References (0)
|